The purpose of the Practice Management and Regulatory Affairs Committee is to respond to, and be proactive around, policies by federal regulatory agencies, public payers (e.g., Medicaid, Medicare, Tricare), private payers (e.g., national, regional and local insurers) and purchasers of health care goods and services (e.g., employers, collective bargaining units) that impact addiction prevention, treatment, and recovery. The Practice Management and Regulatory Affairs Committee will also review and consider the recommendations of ASAM’s CPT and RUC Advisors prior to submission to the relevant AMA committees. Additionally, the Committee is charged with monitoring and developing resources to address the practice management needs of addiction medicine specialty practices to assure that they can deliver optimal quality care for the patients they serve.


Wendy Welch, MD, MBA, FASAM


Mario San Bartolome, MD, MBA, MRO, QME, FASAM


  • Marcus Bachhuber, MD
  • Joel Brill, MD
  • Brad Hall, MD, DFASAM
  • Beth Howell, MD, DFASAM
  • Bob Lubran, MS, MPA
  • Debra Nussbaum, PhD, LCSW
  • Andrey Ostrovsky, MD
  • Shawn Ryan, MD, MBA, FASAM
  • Michael Sprintz, DO, DFASAM




Billing and Coding Subcommittee

The Billing and Coding Subcommittee under the Practice Management and Regulatory Affairs Committee (PMRAC) advises the PMRAC on payment policy and regulatory issues that deal with physician payment, including the development and response to code change applications.